Phosphodiesterase 5 inhibitors: Current status and potential applications

Medicine & Life Sciences

• Phosphodiesterase 5 Inhibitors 82%
• cyclic guanosine monophosphate-adenosine monophosphate 32%
• Type 5 Cyclic Nucleotide Phosphodiesterases 31%
• Pharmaceutical Chemistry 29%
• Sildenafil Citrate 26%
• Phosphoric Diester Hydrolases 24%
• Erectile Dysfunction 22%
• Cyclic AMP 20%
• Psychological Inhibition 17%
• Nucleotides 17%
• Clinical Trials 13%
• Enzymes 11%
• Therapeutics 6%

Chemical Compounds

• Phosphodiesterase V Inhibitor 100%
• Sildenafil 31%
• Application 20%
• Nucleotide 17%
• Chemistry 12%